Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $649.51 | 39 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $191.10 | 9 | $0 (2023) |
| Novo Nordisk Inc | $190.53 | 13 | $0 (2022) |
| Alkermes, Inc. | $44.27 | 2 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $39.31 | 3 | $0 (2023) |
| Lilly USA, LLC | $33.99 | 2 | $0 (2023) |
| Abbott Laboratories | $21.48 | 1 | $0 (2022) |
| Braintree Laboratories, Inc. | $17.70 | 1 | $0 (2023) |
| Indivior Inc. | $14.92 | 1 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $14.37 | 1 | $0 (2023) |
| Kowa Pharmaceuticals America, Inc. | $14.21 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $137.40 | 8 | Lilly USA, LLC ($33.99) |
| 2022 | $348.45 | 21 | Novo Nordisk Inc ($161.95) |
| 2021 | $69.26 | 4 | Boehringer Ingelheim Pharmaceuticals, Inc. ($42.12) |
| 2020 | $38.29 | 2 | Alkermes, Inc. ($23.37) |
| 2019 | $42.40 | 3 | Novo Nordisk Inc ($28.58) |
| 2018 | $13.71 | 1 | AngioDynamics, Inc. ($13.71) |
All Payment Transactions
39 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/20/2023 | Braintree Laboratories, Inc. | SUTAB (Drug), SUFLAVE | Food and Beverage | In-kind items and services | $17.70 | General |
| Category: GI COLON PREP | ||||||
| 04/26/2023 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $20.90 | General |
| Category: CNS | ||||||
| 04/10/2023 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.83 | General |
| Category: Diabetes | ||||||
| 04/04/2023 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, PAXLOVID | Food and Beverage | In-kind items and services | $13.22 | General |
| Category: VACCINES | ||||||
| 02/23/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $17.16 | General |
| Category: Diabetes | ||||||
| 02/01/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $24.23 | General |
| Category: DIABETES | ||||||
| 02/01/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.37 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/10/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $12.99 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/28/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $13.40 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/25/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.71 | General |
| Category: DIABETES | ||||||
| 10/24/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $13.98 | General |
| Category: Diabetes | ||||||
| 09/30/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.66 | General |
| Category: DIABETES | ||||||
| 09/27/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.36 | General |
| Category: Diabetes | ||||||
| 09/26/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $12.92 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/06/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.07 | General |
| Category: DIABETES | ||||||
| 08/26/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $13.57 | General |
| Category: Diabetes | ||||||
| 08/15/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.18 | General |
| Category: DIABETES | ||||||
| 08/03/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $28.95 | General |
| Category: DIABETES | ||||||
| 06/27/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.95 | General |
| Category: Diabetes | ||||||
| 05/26/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $14.76 | General |
| Category: Diabetes | ||||||
| 05/16/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.72 | General |
| Category: Diabetes | ||||||
| 04/11/2022 | Dynavax Technologies Corporation | Heplisav-B (Drug) | Food and Beverage | In-kind items and services | $13.95 | General |
| Category: Hepatitis B Vaccine | ||||||
| 03/07/2022 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $21.48 | General |
| Category: Diabetes Care | ||||||
| 02/28/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $30.18 | General |
| Category: DIABETES | ||||||
| 02/25/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $11.41 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 485 | 577 | $117,367 | $47,122 |
| 2022 | 12 | 601 | 704 | $125,341 | $52,579 |
| 2021 | 8 | 222 | 446 | $114,620 | $32,234 |
| 2020 | 5 | 308 | 620 | $187,795 | $49,853 |
All Medicare Procedures & Services
36 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 175 | 253 | $70,587 | $23,549 | 33.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 69 | 69 | $13,800 | $9,670 | 70.1% |
| 0241U | Respiratory infectious agent detection by rna for severe acute respiratory syndrome coronavirus 2 (covid 19), influenza a, influenza b, and respiratory syncytial virus, upper respiratory specimen, each reported as detected or not detected | Office | 2023 | 29 | 31 | $6,200 | $4,333 | 69.9% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 39 | 39 | $2,758 | $2,689 | 97.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 17 | 17 | $10,098 | $2,327 | 23.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 32 | 35 | $6,335 | $2,227 | 35.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 39 | 39 | $975.00 | $955.50 | 98.0% |
| 87651 | Detection test by nucleic acid for strep (streptococcus, group a), amplified probe technique | Office | 2023 | 15 | 15 | $1,125 | $515.85 | 45.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 40 | 49 | $735.00 | $369.60 | 50.3% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 13 | 13 | $2,340 | $320.01 | 13.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 17 | 17 | $2,414 | $167.18 | 6.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 159 | 217 | $60,543 | $20,171 | 33.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 68 | 68 | $13,600 | $9,974 | 73.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 130 | 138 | $24,978 | $9,745 | 39.0% |
| 0241U | Respiratory infectious agent detection by rna for severe acute respiratory syndrome coronavirus 2 (covid 19), influenza a, influenza b, and respiratory syncytial virus, upper respiratory specimen, each reported as detected or not detected | Office | 2022 | 51 | 53 | $10,600 | $7,423 | 70.0% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 30 | 30 | $2,079 | $1,903 | 91.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 14 | 14 | $5,516 | $1,299 | 23.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 29 | 29 | $725.00 | $712.00 | 98.2% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2022 | 11 | 12 | $1,536 | $514.92 | 33.5% |
| 71046 | X-ray of chest, 2 views | Office | 2022 | 14 | 14 | $1,260 | $298.76 | 23.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 62 | 95 | $1,425 | $273.24 | 19.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 20 | 21 | $2,982 | $236.90 | 7.9% |
| 81003 | Automated urinalysis test | Office | 2022 | 13 | 13 | $97.00 | $28.87 | 29.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 96 | 297 | $71,280 | $18,459 | 25.9% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 16 | 38 | $13,110 | $3,243 | 24.7% |
About Dr. Jaime Rodriguez, MD
Dr. Jaime Rodriguez, MD is a Hospitalist healthcare provider based in Hackensack, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/21/2006. The National Provider Identifier (NPI) number assigned to this provider is 1770504573.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jaime Rodriguez, MD has received a total of $649.51 in payments from pharmaceutical and medical device companies, with $137.40 received in 2023. These payments were reported across 39 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($649.51).
As a Medicare-enrolled provider, Rodriguez has provided services to 1,616 Medicare beneficiaries, totaling 2,347 services with total Medicare billing of $181,788. Data is available for 4 years (2020–2023), covering 36 distinct procedure/service records.
Practice Information
- Specialty Hospitalist
- Location Hackensack, NJ
- Active Since 07/21/2006
- Last Updated 07/13/2018
- Taxonomy Code 208M00000X
- Entity Type Individual
- NPI Number 1770504573
Products in Payments
- JARDIANCE (Drug) $207.93
- Ozempic (Drug) $133.72
- Rybelsus (Drug) $56.81
- ARISTADA (Drug) $44.27
- ENTRESTO (Drug) $26.32
- FREESTYLE LIBRE 2 (Device) $21.48
- SUTAB (Drug) $17.70
- MOUNJARO (Drug) $17.16
- PERSERIS (Drug) $14.92
- FARXIGA (Drug) $14.37
- Livalo (Drug) $14.21
- Heplisav-B (Drug) $13.95
- APTIOM (Drug) $13.82
- PREVNAR 20 (Biological) $13.22
- LEQVIO (Drug) $12.99
- Xofluza (Drug) $12.93
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hospitalist Doctors in Hackensack
Dr. Daniel D'alessandro, Md, MD
Hospitalist — Payments: $1,770
Dr. Sureshbhai Patel, Md, MD
Hospitalist — Payments: $408.66
Dr. Patrick Wu, M.d, M.D
Hospitalist — Payments: $262.23
Dr. Gurpreet Kaur, M.d, M.D
Hospitalist — Payments: $171.42
Gazala Darvesh, M.d, M.D
Hospitalist — Payments: $115.24
Deepti Reddy, Md, MD
Hospitalist — Payments: $102.89